| Title : Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact - Olazaran_2023_Alzheimers.Res.Ther_15_130 |
| Author(s) : Olazaran J , Carnero-Pardo C , Fortea J , Sanchez-Juan P , Garcia-Ribas G , Vinuela F , Martinez-Lage P , Boada M |
| Ref : Alzheimers Res Ther , 15 :130 , 2023 |
| Abstract : Olazaran_2023_Alzheimers.Res.Ther_15_130 |
| ESTHER : Olazaran_2023_Alzheimers.Res.Ther_15_130 |
| PubMedSearch : Olazaran_2023_Alzheimers.Res.Ther_15_130 |
| PubMedID: 37537656 |
| Title : Influence of Educational Attainment on Cognition-Based Intervention Programs for Persons with Mild Alzheimer's Disease - Contador_2016_J.Int.Neuropsychol.Soc__1 |
| Author(s) : Contador I , Fernandez-Calvo B , Ramos F , Olazaran J |
| Ref : J Int Neuropsychol Soc , :1 , 2016 |
| Abstract : Contador_2016_J.Int.Neuropsychol.Soc__1 |
| ESTHER : Contador_2016_J.Int.Neuropsychol.Soc__1 |
| PubMedSearch : Contador_2016_J.Int.Neuropsychol.Soc__1 |
| PubMedID: 26976668 |
| Title : Persistence of cholinesterase inhibitor treatment in dementia: insights from a naturalistic study - Olazaran_2013_Dement.Geriatr.Cogn.Dis.Extra_3_48 |
| Author(s) : Olazaran J , Navarro E , Rojo JM |
| Ref : Dement Geriatr Cogn Dis Extra , 3 :48 , 2013 |
| Abstract : Olazaran_2013_Dement.Geriatr.Cogn.Dis.Extra_3_48 |
| ESTHER : Olazaran_2013_Dement.Geriatr.Cogn.Dis.Extra_3_48 |
| PubMedSearch : Olazaran_2013_Dement.Geriatr.Cogn.Dis.Extra_3_48 |
| PubMedID: 23637699 |
| Title : Psychotropic medications and falls in nursing homes: a cross-sectional study - Olazaran_2013_J.Am.Med.Dir.Assoc_14_213 |
| Author(s) : Olazaran J , Valle D , Serra JA , Cano P , Muniz R |
| Ref : J Am Med Dir Assoc , 14 :213 , 2013 |
| Abstract : Olazaran_2013_J.Am.Med.Dir.Assoc_14_213 |
| ESTHER : Olazaran_2013_J.Am.Med.Dir.Assoc_14_213 |
| PubMedSearch : Olazaran_2013_J.Am.Med.Dir.Assoc_14_213 |
| PubMedID: 23246184 |
| Title : Alzheimer's disease with vascular component: a distinct clinical entity? - Olazaran_2012_Dement.Geriatr.Cogn.Dis.Extra_2_400 |
| Author(s) : Olazaran J , Navarro E , Rojo JM |
| Ref : Dement Geriatr Cogn Dis Extra , 2 :400 , 2012 |
| Abstract : Olazaran_2012_Dement.Geriatr.Cogn.Dis.Extra_2_400 |
| ESTHER : Olazaran_2012_Dement.Geriatr.Cogn.Dis.Extra_2_400 |
| PubMedSearch : Olazaran_2012_Dement.Geriatr.Cogn.Dis.Extra_2_400 |
| PubMedID: 23139685 |
| Title : Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease - Olazaran_2004_Neurology_63_2348 |
| Author(s) : Olazaran J , Muniz R , Reisberg B , Pena-Casanova J , Del Ser T , Cruz-Jentoft AJ , Serrano P , Navarro E , Garcia de la Rocha ML , Frank A , Galiano M , Fernandez-Bullido Y , Serra JA , Gonzalez-Salvador MT , Sevilla C |
| Ref : Neurology , 63 :2348 , 2004 |
| Abstract : Olazaran_2004_Neurology_63_2348 |
| ESTHER : Olazaran_2004_Neurology_63_2348 |
| PubMedSearch : Olazaran_2004_Neurology_63_2348 |
| PubMedID: 15623698 |
| Title : [Galantamine: a novel cholinergic agent for Alzheimer's disease] - Olazaran_2002_Neurologia_17_429 |
| Author(s) : Olazaran J , Garcia G |
| Ref : Neurologia , 17 :429 , 2002 |
| Abstract : Olazaran_2002_Neurologia_17_429 |
| ESTHER : Olazaran_2002_Neurologia_17_429 |
| PubMedSearch : Olazaran_2002_Neurologia_17_429 |
| PubMedID: 12396973 |